Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 5/20 | 0.64 |
| ▸ | PLK3 | Q9H4B4 | 3/20 | 0.64 |
| ▸ | RARB | P10826 | 7/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | RARA | P10276 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | MTOR | P42345 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.57 |
| ▸ | CDC25B | P30305 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL918747 | 0.98 | PLK1 (0.66) | PLK1PLK3RARBMEN1ALDH1A1 | |
| SCHEMBL28111022 | 0.95 | RARB (0.59) | PLK1PLK3RARBAKR1C3CDC25B | |
| SCHEMBL28013663 | 0.89 | AKR1C3 (0.62) | PLK1PLK3ALDH1A1KMT2AAKR1C3 | |
| Phthalic Acid SCHEMBL27963015 | 0.89 | PLK1 (0.71) | PLK1PLK3RARBMEN1ALDH1A1 | |
| Phthalic Acid SCHEMBL28394873 | 0.89 | PLK1 (0.71) | PLK1PLK3RARBMEN1ALDH1A1 | |
| Phthalic Acid SCHEMBL28063825 | 0.87 | PLK1 (0.69) | PLK1PLK3RARBMEN1ALDH1A1 | |
| SCHEMBL11227652 | 0.85 | RARB (0.65) | RARBMEN1ALDH1A1RARAMAPT | |
| Phthalic Acid SCHEMBL28390429 | 0.85 | PLK1 (0.61) | PLK1PLK3RARBALDH1A1 | |
| SCHEMBL4354691 | 0.85 | THRA (0.56) | PLK1PLK3RARBMEN1ALDH1A1 | |
| SCHEMBL5422705 | 0.85 | PLK1 (0.56) | PLK1PLK3RARBMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118173863-A | Organic-inorganic composite electrolyte and preparation and application thereof | 中国科学院大连化学物理研究所 | 2024-06-11 | — | — | CN | claimed |
| CN-118173870-A | Organic-inorganic composite solid electrolyte and preparation and application thereof | 中国科学院大连化学物理研究所 | 2024-06-11 | — | — | CN | claimed |
| CN-113209375-B | Preparation method and application of hydrogel based on arylborate crosslinking and having self-repairing and injectable properties | 温州医科大学 | 2023-01-06 | — | — | CN | claimed |
| CN-111875489-B | 2- (4-pentylbenzoyl) benzoic acid and 2-pentylanthraquinone and preparation method thereof | 中国石油化工股份有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-111875489-A | 2- (4-pentylbenzoyl) benzoic acid and 2-pentylanthraquinone and preparation method thereof | 中国石油化工股份有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-109320414-A | A kind of preparation method of 2- (4- amyl benzoyl) benzoic acid | 中触媒新材料股份有限公司 | 2019-02-12 | — | — | CN | claimed |
| US-9938231-B2 | Liquid arylbenzoyl benzoic acid ester derivatives for energy curable compositions | SUN CHEMICAL CORPORATION (US) | 2018-04-10 | — | — | US | claimed |
| EP-3134379-A1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | Sun Chemical Corporation (US) | 2017-03-01 | — | — | EP | claimed |
| CN-104588088-B | For preparing catalyst of 2 alkyl-anthraquinones and its preparation method and application | 中国石油化工股份有限公司 | 2017-03-01 | — | — | CN | claimed |
| US-20170029360-A1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | SUN CHEMICAL CORPORATION (US) | 2017-02-02 | — | — | US | claimed |
| CN-104588087-B | Catalyst for preparing 2-alkyl anthraquinone, and preparation method and application thereof | 中国石油化工股份有限公司 | 2017-02-01 | — | — | CN | claimed |
| CN-104588107-B | Catalyst used for synthesizing 2-alkylanthraquinone, and preparation method and application thereof | 中国石油化工股份有限公司 | 2017-01-11 | — | — | CN | claimed |
| CN-104588103-B | A kind of catalyst for synthesizing 2-alkyl-anthraquinone and its preparation method and application | 中国石油化工股份有限公司 | 2016-10-26 | — | — | CN | claimed |
| WO-2015164205-A1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | SUN CHEMICAL CORPORATION (US) | 2015-10-29 | — | — | WO | claimed |
| JP-61186344-A | — | — | None | — | — | JP | disclosed |
| JP-61158949-A | — | — | None | — | — | JP | disclosed |
| JP-61158949-A | — | — | None | — | — | JP | disclosed |
| JP-S61158949-A | PRODUCTION OF 2-(4'-AMYLBENZOYL)BENZOIC ACID MIXTURE | TOYO GOSEI KOGYO KK | 1986-07-18 | — | — | JP | disclosed |
| JP-S61158949-A | PRODUCTION OF 2-(4'-AMYLBENZOYL)BENZOIC ACID MIXTURE | TOYO GOSEI KOGYO KK | 1986-07-18 | — | — | JP | disclosed |
| US-4404140-A | Manufacture of alkylanthraquinones | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029360-A1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | ACMSD, AAAS, BAP1 | PLK1 4764/4885PLK3 2965/4885RARB 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.